Navigation Links
Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President
Date:9/28/2010

SOUTH PLAINFIELD, N.J., Sept. 28 /PRNewswire/ -- Prolong Pharmaceuticals today announced that industry veteran Glenn Kazo has assumed the title of President. Mr. Kazo has been consulting in various capacities with Prolong since 2007. He succeeds Prolong founder Dr. Abraham Abuchowski, who remains Chief Executive Officer.

"I have known Glenn for more than thirty years," said Dr. Abuchowski, who co-founded Enzon Pharmaceuticals in 1981 with Mr. Kazo. "I feel he is one of the greatest strategic minds in the biopharmaceutical world today, with a long history of successful experience behind him guiding small companies and startups. Through his consulting input and counsel, Glenn has already played a central role in Prolong's development, and as we move into the next phase of product development he will assume the major operational responsibilities for the company," said Dr. Abuchowski.

At Enzon, Kazo headed the steering committee for the blockbuster cancer drug PEG-Interferon. As Vice President of Sales and Marketing he built and managed a significant business development and licensing group and launched the company's first two drugs, Adagen® and Oncaspar® . Following Enzon, Kazo joined Focal, Inc., now a division of Genzyme, and helped take that company public. He later served as US General Manager and a member of the Board of Directors for the UK-listed public company XTL Biopharmaceuticals, and subsequently as Chief Business Office for Activbiotics a private VC backed anti-infective company.  Kazo has been responsible for raising over $300M in capital from international investors, including a leading role in three successful IPOs.

About Prolong Pharmaceuticals

Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing biopharmaceutical products targeting the treatment of anemia resulting from an oxygen deficiency. First founded in 2002 as a research company Prolong is focused on sickle cell anemia, diabetic ischemia, and several trauma indications. The company's senior management team includes inventors of the most successful drug delivery technology in pharmaceutical history, PEGylation, now responsible for more than $30 billion in drug sales worldwide. For more information visit: www.prolongpharmaceuticals.com.


'/>"/>
SOURCE Prolong Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Updated Results from Phase 2 Trial Demonstrate Prolonged Hematologic Relapse-Free Survival of Micromets Blinatumomab in Patients with Acute Lymphoblastic Leukemia
2. Trauma 411: Prolonged Surgery Should be Avoided in Certain Cases
3. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
4. Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer
5. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
6. Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
7. Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI
8. Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma
9. Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission
10. Treating Depression Prolongs Life for Older People with Diabetes
11. Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control & Sexual Function in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to 2022 ... Market Outlook to 2022", provides key market data on ... value, in millions of US dollars, volume (in units) ... Micro Catheters and Glaucoma Drainage Devices. The report ... each of these market segements, and global corporate-level profiles ...
(Date:12/5/2016)... , Dec. 5, 2016 Special purpose needles ... samples such as fluid and cells from organs or lumps ... shapes, and sizes. The global market for special purpose needles ... population. In terms of revenue, the global special purpose needles ... during the forecast period (2016–2026) and is expected to be ...
(Date:12/5/2016)... RATON, Fla. , Dec. 5, 2016 /PRNewswire-USNewswire/ ... Public Research (the Florida Institute) announced today ... LLC, an Orlando -based company ... The Florida Institute supports new company creation based ... for companies spinning out of Florida-based universities and research ...
Breaking Medicine Technology:
(Date:12/5/2016)... Tacoma, Washington (PRWEB) , ... December 05, 2016 ... ... grand opening of its latest transitional care facility – Avamere Transitional Care ... The 39,936 square foot short-term, post-acute health care center will provide patients recovering ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... with leading global lifestyle design firm kathy ireland® Worldwide for five additional years, ... Worldwide entered into an exclusive licensing agreement three years ago to design and ...
(Date:12/5/2016)... Louis, Missouri (PRWEB) , ... December 05, 2016 ... ... across ethnic, gender, and geographic lines. The goal of Castlewood Treatment Centers has ... disorder treatment accessible to as many people as possible. In that spirit, ...
(Date:12/5/2016)... ... December 05, 2016 , ... Florida Hospital ... Hospital West Florida Region. McGuinness brings experience in executive leadership and clinical practice, ... and leaders. , In her new role, that officially begins December 12, 2016, ...
(Date:12/5/2016)... ... ... Sabah Shah MD, MBA has joined the Retina Group of New York (RGONY) ... James M. Maisel, MD and has been providing tertiary medical and surgical retinal care on ... surpassing expectations amongst her peers. Growing up in a family of doctors, Dr. Shah ...
Breaking Medicine News(10 mins):